DPYS anticorps (Middle Region)
-
- Antigène Voir toutes DPYS Anticorps
- DPYS (Dihydropyrimidinase (DPYS))
-
Épitope
- Middle Region
-
Reactivité
- Humain, Souris, Rat, Lapin, Boeuf (Vache), Poisson zèbre (Danio rerio), Chien, Cobaye, Cheval
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp DPYS est non-conjugé
-
Application
- Western Blotting (WB)
- Séquence
- LRPDPSTPDF LMNLLANDDL TTTGTDNCTF NTCQKALGKD DFTKIPNGVN
- Homologie
- Cow: 100%, Dog: 100%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 100%, Zebrafish: 100%
- Attributs du produit
- This is a rabbit polyclonal antibody against DPYS. It was validated on Western Blot using a cell lysate as a positive control.
- Purification
- Protein A purified
- Immunogène
- The immunogen is a synthetic peptide directed towards the middle region of human DPYS
- Top Product
- Discover our top product DPYS Anticorps primaire
-
-
- Indications d'application
- Optimal working dilutions should be determined experimentally by the investigator.
- Commentaires
-
Antigen size: 519 AA
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Middle cerebral artery stenosis increased the risk of vascular disease mortality among type 2 diabetic patients." dans: Cerebrovascular diseases (Basel, Switzerland), Vol. 25, Issue 3, pp. 261-7, (2008) (PubMed).
: "
-
Middle cerebral artery stenosis increased the risk of vascular disease mortality among type 2 diabetic patients." dans: Cerebrovascular diseases (Basel, Switzerland), Vol. 25, Issue 3, pp. 261-7, (2008) (PubMed).
-
- Antigène
- DPYS (Dihydropyrimidinase (DPYS))
- Autre désignation
- DPYS (DPYS Produits)
- Synonymes
- anticorps DHP, anticorps DHPase, anticorps 1200017I10Rik, anticorps 1300004I01Rik, anticorps dhp, anticorps dihydropyrimidinase, anticorps dihydropyrimidinase L homeolog, anticorps DPYS, anticorps Dpys, anticorps Jann_1488, anticorps hydA, anticorps h16_A3075, anticorps Veis_0725, anticorps AZC_1966, anticorps M446_2543, anticorps RSKD131_3628, anticorps Vapar_5601, anticorps Rleg_5687, anticorps LOC9307588, anticorps EIO_3239, anticorps blr3333, anticorps BAV0676, anticorps hyuA, anticorps CtCNB1_2936, anticorps dpyS, anticorps Pat9b_1914, anticorps dpys, anticorps dpys.L
- Sujet
-
Dihydropyrimidinase catalyzes the conversion of 5,6-dihydrouracil to 3-ureidopropionate in pyrimidine metabolism. Dihydropyrimidinase is expressed at a high level in liver and kidney as a major 2.5-kb transcript and a minor 3.8-kb transcript. Defects in the DPYS gene are linked to dihydropyrimidinuria.Dihydropyrimidinase catalyzes the conversion of 5,6-dihydrouracil to 3-ureidopropionate in pyrimidine metabolism. Dihydropyrimidinase is expressed at a high level in liver and kidney as a major 2.5-kb transcript and a minor 3.8-kb transcript. Defects in the DPYS gene are linked to dihydropyrimidinuria.
Alias Symbols: DHP, DHPase
Protein Interaction Partner: DPYSL5,
Protein Size: 519 - Poids moléculaire
- 56 kDa
- ID gène
- 1807
- NCBI Accession
- NM_001385, NP_001376
- UniProt
- Q14117
-